These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 21116316

  • 1. Rejection and function and chronic allograft dysfunction.
    de Fijter JW.
    Kidney Int Suppl; 2010 Dec; (119):S38-41. PubMed ID: 21116316
    [Abstract] [Full Text] [Related]

  • 2. Utility of Serial Protocol Biopsies Performed After 1 Year in Predicting Long-Term Kidney Allograft Function According to Histologic Phenotype.
    Zachariah MS, Dwivedi AK, Yip CS, Chang SS, Gundroo A, Venuto RC, Tomaszewski J, Patel SK, Sharma R.
    Exp Clin Transplant; 2018 Aug; 16(4):391-400. PubMed ID: 29206090
    [Abstract] [Full Text] [Related]

  • 3. Longitudinal analysis of chronic allograft nephropathy: clinicopathologic correlations.
    Chapman JR.
    Kidney Int Suppl; 2005 Dec; (99):S108-12. PubMed ID: 16336561
    [Abstract] [Full Text] [Related]

  • 4. Protocol biopsies for renal transplantation.
    Rush D.
    Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):1-9. PubMed ID: 20061686
    [Abstract] [Full Text] [Related]

  • 5. Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation.
    Shimizu T, Toma H, Hayakawa N, Shibahara R, Ishiyama R, Hayashida A, Fujimori D, Tsunoyama K, Ikezawa E, Kitajima S, Iida S, Ishida H, Tanabe K, Honda K, Koike J.
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():26-30. PubMed ID: 26972969
    [Abstract] [Full Text] [Related]

  • 6. Chronic allograft nephropathy--biopsy findings and outcome.
    Freese P, Svalander CT, Mölne J, Nordén G, Nyberg G.
    Nephrol Dial Transplant; 2001 Dec; 16(12):2401-6. PubMed ID: 11733633
    [Abstract] [Full Text] [Related]

  • 7. Treatment of subclinical injuries detected by protocol biopsy improves the long-term kidney allograft function: a single center prospective randomized clinical trial.
    Szederkényi E, Iványi B, Morvay Z, Szenohradszki P, Borda B, Marofka F, Kemény E, Lázár G.
    Transplant Proc; 2011 May; 43(4):1239-43. PubMed ID: 21620099
    [Abstract] [Full Text] [Related]

  • 8. Chronic renal allograft dysfunction (CAD): new frontiers. Introduction.
    Sayegh MH.
    Kidney Int Suppl; 2010 Dec; (119):S1. PubMed ID: 21116309
    [No Abstract] [Full Text] [Related]

  • 9. Effect of histological damage on long-term kidney transplant outcome.
    Nankivell BJ, Fenton-Lee CA, Kuypers DR, Cheung E, Allen RD, O'Connell PJ, Chapman JR.
    Transplantation; 2001 Feb 27; 71(4):515-23. PubMed ID: 11258430
    [Abstract] [Full Text] [Related]

  • 10. The pathology of chronic allograft dysfunction.
    Racusen LC, Regele H.
    Kidney Int Suppl; 2010 Dec 27; (119):S27-32. PubMed ID: 21116314
    [Abstract] [Full Text] [Related]

  • 11. Risk factors associated with the deterioration of renal function: the role of protocol biopsies.
    Serón D.
    Prilozi; 2007 Jul 27; 28(1):291-302. PubMed ID: 17932475
    [Abstract] [Full Text] [Related]

  • 12. Effect of steroid-free low concentration calcineurin inhibitor maintenance immunosuppression regimen on renal allograft histopathology and function.
    Nainani N, Patel N, Tahir N, Kumar R, Weber-Shrikant E, Gundroo AA, Murray BM, Tornatore KM, Blessios GA, Venuto RC.
    Nephrol Dial Transplant; 2012 May 27; 27(5):2077-83. PubMed ID: 22058172
    [Abstract] [Full Text] [Related]

  • 13. Arteriosclerosis in zero-time biopsy is a risk factor for tacrolimus-induced chronic nephrotoxicity.
    Yagisawa T, Omoto K, Shimizu T, Ishida H, Tanabe K.
    Nephrology (Carlton); 2015 Jul 27; 20 Suppl 2():51-7. PubMed ID: 26031587
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of Indication Biopsies ≥5 Years After Kidney Transplant: A Single-Center Experience.
    Tatar E, Simsek C, Tasli F, Cayhan VK, Karatas M, Uslu A.
    Exp Clin Transplant; 2017 Feb 27; 15(Suppl 1):265-268. PubMed ID: 28260483
    [Abstract] [Full Text] [Related]

  • 15. Chronic allograft nephropathy.
    Najafian B, Kasiske BL.
    Curr Opin Nephrol Hypertens; 2008 Mar 27; 17(2):149-55. PubMed ID: 18277147
    [Abstract] [Full Text] [Related]

  • 16. Protocol graft biopsy in kidney transplantation.
    Sakai K, Oguchi H, Muramatsu M, Shishido S.
    Nephrology (Carlton); 2018 Jul 27; 23 Suppl 2():38-44. PubMed ID: 29968403
    [Abstract] [Full Text] [Related]

  • 17. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B, Canver B, Gurlek Demirci B, Colak T, Ozdemir BH, Haberal M.
    Exp Clin Transplant; 2017 Feb 27; 15(Suppl 1):32-36. PubMed ID: 28260428
    [Abstract] [Full Text] [Related]

  • 18. Improvement of renal function after the switch from a calcineurin inhibitor to everolimus in liver transplant recipients with chronic renal dysfunction.
    Castroagudín JF, Molina E, Romero R, Otero E, Tomé S, Varo E.
    Liver Transpl; 2009 Dec 27; 15(12):1792-7. PubMed ID: 19938140
    [Abstract] [Full Text] [Related]

  • 19. Immunosuppressive treatment and progression of histologic lesions in kidney allografts.
    Morales JM.
    Kidney Int Suppl; 2005 Dec 27; (99):S124-30. PubMed ID: 16336565
    [Abstract] [Full Text] [Related]

  • 20. Infection and chronic allograft dysfunction.
    Dupont PJ, Manuel O, Pascual M.
    Kidney Int Suppl; 2010 Dec 27; (119):S47-53. PubMed ID: 21116318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.